Other studies have shown that the CRP levels and dyslipidemia have a synergistic effect on the pathogenesis of CAD, and the association between dyslipidemia and CAD appears to be enhanced by elevated CRP levels [22]. This evidence concerns the gene CRP and metabolic syndrome.